Fidelity's passive stake is unchanged at 0.9%, indicating no material conviction signal. The filing is routine and follows the Q3 earnings release. Monitor for any future 13D conversion or significant stake changes, but no immediate action warranted.
EWTX drugs
EWTX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $38.87entry
- T+1 · 11d ago +15.87%α +15.56% · $45.04
- T+5 · 5d ago +17.88%α +14.59% · $45.82
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 970,920 shares of Edgewise Therapeutics common stock as of September 30, 2026, representing 0.9% of shares outstanding. This is a routine passive stake update filed one day after Edgewise reported Q3 results that included a large one-time gain from the sale of sevasemten. The stake is unchanged from the prior filing, and the filing carries no directional signal.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 970,920 shares of Edgewise Therapeutics common stock as of September 30, 2026
- The stake represents 0.9% of shares outstanding
- This is an amendment to a prior Schedule 13G filed August 6, 2026
- The filing was made under Rule 13d-1(b) indicating passive investment intent
- Filed one day after Edgewise reported Q3 2026 earnings with a $1.348 billion gain on sale of sevasemten
Financial Impact
Stake valued at approximately $36.9 million based on $4.1B market cap and 0.9% ownership
Risk Factors
- No material risks identified from this routine passive stake filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002741 |
| Document: 0000315066-26-002741-index-headers.html | 0000315066-26-002741 |
| Document: 0000315066-26-002741-index.html | 0000315066-26-002741 |
| Document: 0000315066-26-002741.txt | 0000315066-26-002741 |
Track record
14 reports on EWTX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 144 Neutral 1/10 Entry $43.68 Now $43.68 +0.00% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $44.09 Now $43.68 −0.93% settles Feb 12
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $38.87 Now $43.68 +12.37% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $38.87 Now $43.68 +12.37% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.68 Now $43.68 +15.92% settles Feb 1
- Aug 14, 202613w ago Insider Cluster Neutral 4/10 Entry $44.04 to $46.53 Now $43.68 −0.82% ▲ +5.65% +8.60% vs SPY
- Aug 14, 202613w ago Insider Cluster Neutral 3/10 Entry $44.04 to $46.53 Now $43.68 −0.82% ▲ +5.65% +8.60% vs SPY
- Aug 6, 202614w ago 8-K Mixed 7/10 Entry $44.42 to $38.90 Now $43.68 −1.67% ▼ −12.43% −10.76% vs SPY
- Jul 13, 202618w ago 8-K Bullish 7/10 Entry $41.27 to $40.02 Now $43.68 +5.84% ▼ −3.03% −7.02% vs SPY
- Jun 1, 202624w ago 8-K Bullish 8/10 Entry $40.26 to $44.21 Now $43.68 +8.49% ▲ +9.81% +8.58% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers